SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-063124
Filing Date
2023-11-13
Accepted
2023-11-13 17:17:05
Documents
1
Period of Report
2023-11-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3861
  Complete submission text file 0000950170-23-063124.txt   5579
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 401 WALTHAM MA 02453
Business Address
Harmon Seth (Reporting) CIK: 0001993300 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 231400071